HERNEXEOS vs PORTRAZZA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. HERNEXEOS and PORTRAZZA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	HERNEXEOS	PORTRAZZA
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ZONGERTINIB	NECITUMUMAB
Manufacturer	Boehringer Ingelheim	Eli Lilly Co
Dosage forms	Tablet	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Non-Small-Cell Lung Carcinoma

hernexeos portrazza

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

ZONGERTINIB

NECITUMUMAB

Manufacturer

Boehringer Ingelheim

Eli Lilly Co

Dosage forms

Tablet

Injectable

Drug class

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Frequently asked questions

Which is better-rated, Hernexeos or Portrazza?

Hernexeos and Portrazza are tied at 3.6 out of 5 by our independent rating.

What is the difference between Hernexeos and Portrazza?

Hernexeos contains Zongertinib, while Portrazza contains Necitumumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.